Hence, in order to reproduce in vitro an effect observed in vivo obtained after several weeks of treatment, it appears to be necessary to increase the drug concentrations for in vitro determination
Along with the fully updated list, WADA also released their 2025 Summary of Major Modifications and Explanatory Notes, which focuses specifically on the changes between the 2024 and 2025 lists
10.1371/journal.pone.0144033 54 DhimanM.CoronadoY
Hayashi T, Fujita K, Nojima S, Hayashi Y, Nakano K, Ishizuya Y, Wang C, Yamamoto Y, Kinouchi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Nagahara A, Ujike T, Uemura M, Pena MDCR, Gordetsky JB, Morii E, Tsujikawa K, Netto GJ, Nonomura N
Access this article Similar content being viewed by others Notes Use of tradenames is for product identification only and does not imply endorsement